The increasing complexity of malignant diseases treatment necessitates a in-depth understanding of diverse healthcare approaches. This article aims to investigate the strengths and limitations of transatlantic cancer care, evaluating the treatment protocols in both North America and the European Union. Through a multifaceted lens, we will examine k